CRK and breast carcinoma: Whereas overexpression with CrkII-Y239F, like wild-type CrkII, increased migration of Crk-null fibroblasts and Hs683 glioblastoma cells, CrkII-Y239F, unlike wild-type CrkII, failed to increase migration of 4T1 breast cancer cells [56].